Camilla Zettel

1.2k total citations
2 papers, 15 citations indexed

About

Camilla Zettel is a scholar working on Rheumatology, Genetics and Hematology. According to data from OpenAlex, Camilla Zettel has authored 2 papers receiving a total of 15 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Rheumatology, 1 paper in Genetics and 1 paper in Hematology. Recurrent topics in Camilla Zettel's work include Rheumatoid Arthritis Research and Therapies (2 papers), Biosimilars and Bioanalytical Methods (1 paper) and Pharmaceutical Economics and Policy (1 paper). Camilla Zettel is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (2 papers), Biosimilars and Bioanalytical Methods (1 paper) and Pharmaceutical Economics and Policy (1 paper). Camilla Zettel collaborates with scholars based in Norway. Camilla Zettel's co-authors include Paweł Mielnik, Erik Rødevand, Glenn Haugeberg, Andreas P. Diamantopoulos, Gunnstein Bakland, Espen A. Haavardsholm and Mari Hoff and has published in prestigious journals such as BMC Health Services Research.

In The Last Decade

Camilla Zettel

1 paper receiving 15 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camilla Zettel Norway 1 14 11 5 2 2 2 15
M. Ricci Italy 3 12 0.9× 11 1.0× 9 1.8× 1 0.5× 3 15
Benjamin James Wilson Australia 2 20 1.4× 12 1.1× 8 1.6× 2 20
Helena Marzo-Ortega United Kingdom 2 23 1.6× 20 1.8× 12 2.4× 3 23
Akpabio Akpabio Nigeria 3 10 0.7× 4 0.4× 7 1.4× 1 0.5× 10 18
Alejandro Olivé-Marqués Spain 3 6 0.4× 4 0.4× 4 0.8× 2 1.0× 6 11
Joo Sung Shim South Korea 3 14 1.0× 12 1.1× 2 0.4× 2 1.0× 4 21
I Orbán Hungary 3 9 0.6× 5 0.5× 8 1.6× 1 0.5× 11 16
Zhenbin Li China 3 9 0.6× 6 0.5× 2 0.4× 1 0.5× 7 16
Hongguo Zhu China 3 8 0.6× 9 0.8× 3 18
A. V. Elonakov Russia 3 13 0.9× 7 0.6× 11 20

Countries citing papers authored by Camilla Zettel

Since Specialization
Citations

This map shows the geographic impact of Camilla Zettel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Zettel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Zettel more than expected).

Fields of papers citing papers by Camilla Zettel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Zettel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Zettel. The network helps show where Camilla Zettel may publish in the future.

Co-authorship network of co-authors of Camilla Zettel

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Zettel. A scholar is included among the top collaborators of Camilla Zettel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Zettel. Camilla Zettel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Diamantopoulos, Andreas P., Mari Hoff, Camilla Zettel, et al.. (2023). Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010–2019). BMC Health Services Research. 23(1). 968–968.
2.
Diamantopoulos, Andreas P., Espen A. Haavardsholm, Camilla Zettel, et al.. (2022). Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010–2019 – a country with a national tender system for prescription of costly drugs. BMC Health Services Research. 22(1). 48–48. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026